Read more about where to go when your child isnt feeling well
Over 68 weeks, those in the semaglutide group lost an average of 14.9 percent of their baseline body weight, versus just 2.4 percent in the control group, with the treatment effect yielding a 12.4 percent greater reduction in body weight compared to placebo
Together, these peptides are investigated for their potential to support growth hormone and IGF-1 production while maintaining targeted activity
Figueroa-Vega N, Alfonso-Prez M, Benedicto I, Snchez-Madrid F, Gonzlez-Amaro R, Marazuela M
Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: The STEP 3 randomized clinical trial
Retrieved October 1, 2010